Opthea Ltd (ASX:OPT)

APAC company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - OPT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - OPT

  • Market CapAUD0.000m
  • SymbolASX:OPT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000OPT2

Company Profile

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.Opthea Ltd, formerly Circadian Technologies Ltd develops and commercializes therapies for cancer, eye diseases, and others. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets.

Latest OPT news

Currently there for this company. Visit our news hub for other news .